Xtant Medical Holdings has entered into a securities purchase agreement with accredited investors to issue 20,000,000 shares of common stock at a price of $0.75, in a private placement expected to generate $15.0 million in gross proceeds. The proceeds will be used for working capital and general corporate purposes.